Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


Articles published in Am J Surg

Retrieve available abstracts of 40 articles:
HTML format



Single Articles


    July 2022
  1. STEINL GK, Stewart LA, McManus C, Lee JA, et al
    Ethanol ablation for the treatment of benign thyroid nodules.
    Am J Surg. 2022;224.
    PubMed     Abstract available


  2. SUTTON W, Crepeau PK, Canner JK, Karzai S, et al
    Impact of the 2015 American thyroid association guidelines on treatment in older adults with low-risk, differentiated thyroid cancer.
    Am J Surg. 2022;224.
    PubMed     Abstract available


    April 2022
  3. ZMIJEWSKI P, Kuo LE
    Can less Be more in the treatment of cN1a papillary thyroid microcarcinoma?
    Am J Surg. 2022;223:633-634.
    PubMed    


  4. RAMONELL KM, Yip L
    The impact of race and ethnicity on thyroid nodules, malignancy risk, and surgical management.
    Am J Surg. 2022;223:615-616.
    PubMed    


  5. ZHENG H, Lai V, Lu J, Kang JK, et al
    Comparing the rate and extent of malignancy in surgically excised thyroid nodules across race and ethnicity.
    Am J Surg. 2022;223:617-623.
    PubMed     Abstract available


  6. RAMONELL KM, Rentas C, Buczek E, Porterfield J Jr, et al
    Mediastinal parathyroidectomy: Utilization of a multidisciplinary, robotic-assisted transthoracic approach in challenging cases.
    Am J Surg. 2022;223:681-685.
    PubMed     Abstract available


  7. MATSON J, Lwin TM, Bouvet M
    Rapid intraoperative perfusion assessment of parathyroid adenomas with ICG using a wide-field portable hand-held fluorescence imaging system.
    Am J Surg. 2022;223:686-693.
    PubMed     Abstract available


    February 2022
  8. REILLY J, Faridmoayer E, Lapkus M, Pastewski J, et al
    Vascular invasion predicts advanced tumor characteristics in papillary thyroid carcinoma.
    Am J Surg. 2022 Feb 10. pii: S0002-9610(22)00091.
    PubMed    


  9. SHALABY M, Hadedeya D, Toraih EA, Razavi MA, et al
    Predictive factors of radioiodine therapy failure in Graves' Disease: A meta-analysis.
    Am J Surg. 2022;223:287-296.
    PubMed     Abstract available


    January 2022
  10. KELLEY S, Beck AC, Weigel RJ, Howe JR, et al
    Influence of endocrine multidisciplinary tumor board on patient management and treatment decision making.
    Am J Surg. 2022;223:76-80.
    PubMed     Abstract available


    December 2021
  11. REILLY J, Faridmoayer E, Lapkus M, Pastewski J, et al
    Vascular invasion predicts advanced tumor characteristics in papillary thyroid carcinoma.
    Am J Surg. 2021 Dec 9. pii: S0002-9610(21)00724.
    PubMed     Abstract available


    October 2021
  12. ARYANPOUR Z, Asban A, Boyd C, Herring B, et al
    A single institution experience with papillary thyroid cancer: Are outcomes better at comprehensive cancer centers?
    Am J Surg. 2021;222:802-805.
    PubMed     Abstract available


    September 2021
  13. RAMONELL KM, Fazendin J
    The complex and heterogeneous entity of double adenomas in primary hyperparathyroidism.
    Am J Surg. 2021;222:481-482.
    PubMed    


  14. GOODSELL KE, Ermer JP, Zaheer S, Kelz RR, et al
    Double adenoma as a cause of primary hyperparathyroidism: Asymmetric hyperplasia or a distinct pathologic entity?
    Am J Surg. 2021;222:483-489.
    PubMed     Abstract available


  15. LIMBERG J, Stefanova D, Thiesmeyer JW, Ullmann TM, et al
    Association of medicaid expansion of the Affordable Care Act with the stage at diagnosis and treatment of papillary thyroid cancer: A difference-in-differences analysis.
    Am J Surg. 2021;222:562-569.
    PubMed     Abstract available


    August 2021
  16. BACK K, Lee J, Choe JH, Kim JH, et al
    Total thyroidectomy can be overtreatment in cN1a papillary thyroid carcinoma patients whose tumor is smaller than 1 cm.
    Am J Surg. 2021 Aug 12. pii: S0002-9610(21)00474.
    PubMed     Abstract available


  17. SINCLAIR CF, Tellez MJ, Pelaez-Cruz R, Diaz-Baamonde A, et al
    Continuous neuromonitoring during radiofrequency ablation of benign thyroid nodules provides objective evidence of laryngeal nerve safety.
    Am J Surg. 2021;222:354-360.
    PubMed     Abstract available


    July 2021
  18. MCDOW AD, Roman BR, Saucke MC, Jensen CB, et al
    Factors associated with physicians' recommendations for managing low-risk papillary thyroid cancer.
    Am J Surg. 2021;222:111-118.
    PubMed     Abstract available


  19. MUSAVI LS, Fadavi D, He W, Sacks JM, et al
    Impact of payer status and hospital volume on outcomes after head and neck oncologic reconstruction.
    Am J Surg. 2021;222:173-178.
    PubMed     Abstract available


    June 2021
  20. SCHWEITZER CL, Wiseman SM
    Adoption of intraoperative nerve monitoring for thyroidectomy: Supported by real-world NSQIP data.
    Am J Surg. 2021;221:1285-1290.
    PubMed    


  21. WISEMAN SM, Saleh N, Tootooni A, Eshraghi P, et al
    Parathyroid identification during thyroid and parathyroid operations: A pilot study evaluating a novel low cost autofluorescence based device.
    Am J Surg. 2021;221:1150-1158.
    PubMed     Abstract available


    May 2021
  22. ESCE AR, Redemann JP, Sanchez AC, Olson GT, et al
    Predicting nodal metastases in papillary thyroid carcinoma using artificial intelligence.
    Am J Surg. 2021 May 13. pii: S0002-9610(21)00281.
    PubMed     Abstract available


  23. NYLEN C, Eriksson FB, Yang A, Aniss A, et al
    Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer.
    Am J Surg. 2021;221:886-892.
    PubMed     Abstract available


    April 2021
  24. WILSON M, Patel A, Goldner W, Baker J, et al
    Postoperative thyroid hormone supplementation rates following thyroid lobectomy.
    Am J Surg. 2021;221:804-808.
    PubMed     Abstract available


    March 2021
  25. BORTZ MD, Khokar A, Winchester DJ, Moo-Young TA, et al
    Radioactive iodine-125 seed localization as an aid in reoperative neck surgery.
    Am J Surg. 2021;221:534-537.
    PubMed     Abstract available


  26. TAKEDA FR, Kodama Pertille Ramos MF, Pereira MA, Muniz RR, et al
    Predictive factors of recurrence in adenocarcinoma of the esophagogastric junction in the multimodal era.
    Am J Surg. 2021;221:631-636.
    PubMed     Abstract available


    February 2021
  27. SAHLI ZT, Canner JK, Zeiger MA, Mathur A, et al
    Association between age and disease specific mortality in medullary thyroid cancer.
    Am J Surg. 2021;221:478-484.
    PubMed     Abstract available


  28. WRENN SM, Wang TS, Toumi A, Kiernan CM, et al
    Practice patterns for surgical management of low-risk papillary thyroid cancer from 2014 to 2019: A CESQIP analysis.
    Am J Surg. 2021;221:448-454.
    PubMed     Abstract available


    January 2021
  29. ATAS H, Korukluoglu B, Ozdemir BA, Yaksi N, et al
    Diagnostic value of modified systemic inflammation score for prediction of malignancy in patients with indeterminate thyroid nodules.
    Am J Surg. 2021;221:117-121.
    PubMed     Abstract available


  30. SUTTON W, Canner JK, Rooper LM, Prescott JD, et al
    Is patient age associated with risk of malignancy in a >/=4 cm cytologically benign thyroid nodule?
    Am J Surg. 2021;221:111-116.
    PubMed     Abstract available


    November 2020
  31. WILSON M, Patel A, Goldner W, Baker J, et al
    Postoperative thyroid hormone supplementation rates following thyroid lobectomy.
    Am J Surg. 2020;220:1169-1173.
    PubMed     Abstract available


    September 2020
  32. DREAM S, Wang TS
    The best localization is an experienced parathyroid surgeon.
    Am J Surg. 2020;220:532.
    PubMed    


  33. SU A, Zhao W, Wu W, Wei T, et al
    The association of preoperative thyroid-stimulating hormone level and the risk of differentiated thyroid cancer in patients with thyroid nodules: A systematic review and meta-analysis.
    Am J Surg. 2020;220:634-641.
    PubMed     Abstract available


    August 2020
  34. SHENG L, Shi J, Han B, Lv B, et al
    Predicting factors for central or lateral lymph node metastasis in conventional papillary thyroid microcarcinoma.
    Am J Surg. 2020;220:334-340.
    PubMed     Abstract available


    July 2020
  35. ZHENG R, Rios-Diaz AJ, Liem S, Devin CL, et al
    Is the placement of jejunostomy tubes in patients with esophageal cancer undergoing esophagectomy associated with increased inpatient healthcare utilization? An analysis of the National Readmissions Database.
    Am J Surg. 2020 Jul 25. pii: S0002-9610(20)30381.
    PubMed     Abstract available


  36. PLAT VD, Stam WT, Schoonmade LJ, Heineman DJ, et al
    Implementation of robot-assisted Ivor Lewis procedure: Robotic hand-sewn, linear or circular technique?
    Am J Surg. 2020;220:62-68.
    PubMed     Abstract available


    June 2020
  37. SYME N, Olson G, Spafford MF, Boyd N, et al
    Microvascular clamp technique as a reversible simulation of parathyroid gland excision.
    Am J Surg. 2020;219:943-946.
    PubMed     Abstract available


    May 2020
  38. SAKAI M, Sohda M, Saito H, Ubukata Y, et al
    Impact of combined assessment of systemic inflammation and presarcopenia on survival for surgically resected esophageal cancer.
    Am J Surg. 2020 May 27. pii: S0002-9610(20)30296.
    PubMed     Abstract available


    March 2020
  39. KHOKAR A, Kuchta K, Abadin S, Moo-Young T, et al
    Discussion on: Increasing trend of bilateral neck exploration in primary hyperparathyroidism.
    Am J Surg. 2020;219:471.
    PubMed    


    January 2020
  40. SDRALIS E, Tzaferai A, Davakis S, Syllaios A, et al
    Reinforcement of intrathoracic oesophago-gastric anastomosis with fibrin sealant (Tisseel(R)) in oesophagectomy for cancer: A prospective comparative study.
    Am J Surg. 2020;219:123-128.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: